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Abstract
Molecular Dynamic Simulations of CRISPR and HIV
In the United States, there were 37,600 new HIV infections in 2014, with an estimated 1.1 million people living with the disease in 2015, 
according to the CDC. HIV targets the cell receptor CD4 and chemocine coreceptors CCR5 or CXCR5. Some individuals possess a mutation 
within CCR5 that causes a resistance to HIV-1. One HIV+ patient in Berlin, Timothy Brown, developed an immunity to the virus after a bone 
marrow transplant from a donor who possessed this CCR5 mutation. After this coincidence, researchers attempted a variety of gene therapies, 
such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and Cas9. CRISPR/Cas9 is a promising new tool 
that scientists have been using to do direct editing of genomes with more ease and specificity than ever before. CRISPR stands for cluster of 
regularly interspaced palindromic repeats, which are segments of RNA that are found in many prokaryotes to defend the organism against viral 
infections and unwanted gene transfers. Cas is a gene cluster that mediates the response to the RNA encoded in the CRISPR segments. Cas are 
designated by the protein complex responsible for interference. Together, these molecules identify a segment of target RNA, extract it, and 
replace it with another segment. They make up part of the adaptive immune system of eukaryotic cells. This research hopes to create a predictive 
model by analyzing the existing gene therapy data from previous studies, and using numerical molecular dynamic simulation software to glean 
more information about those results. Previously published studies discuss how gene therapies such as ZFN and CRISPR are used to modify 
either the host genome or the viral genome3, and then experiments are performed to determine whether this therapy is effective at preventing viral 
infection. By analyzing the bonding characteristics of different strands of RNA, it may be possible to predict which RNA segments make the best 
candidates for gene therapies that will confer resistance to HIV infection.
Faculty Research Day, University of Bridgeport,  2018
Jesse Newman, Prabir Patra, Isaac Macwan
Department of Biomedical Engineering, University of Bridgeport 
1. Method
1.1 Control – Dynamics of 2xlk
The PDB file 2xlk represents the crystal
structure of Csy4 in complex with a segment
of RNA1. As a control, chains A and C of
2xlk was simulated for 20.1 ns. By
comparing the characteristics of these
molecules with other guide RNA strands, the
success of the simulation can be gleaned.
1.2 gRNA types 1, 6, and 7
Hou and team2 used CRISPR with different
mutations of characteristic RNA strands to
remove the CXCR4 gene, which is one of the
pathways that HIV uses to infect human
CD4
+ T cells. Different RNA strands had
different success rates in preventing HIV
infection.
The crux of this research was to determine if
there was a difference in the bonding
characteristics of the different RNA strands
that caused the differences in viral resistance,
using molecular dynamic simulations.
3. Conclusion
Conclusions are still very much preliminary. Looking at the Rmsd of
the control PDB file, 2xlk_AC (not shown), it seems that this has
already equilibrated. Since this is an x-ray of a molecule in vitro, this
stands to reason.
The differences between the control RNA type #1, and the mutated
type #6 and type #7 are apparent in the data collected by Hou et al2,
but more simulations need to be done before their performance as
gene modifiers can be predicted using VMD simulations.
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Figure 2a, 2b, 2c: Comparison of electrostatic energies of wild type
RNA #1 (top) and mutated RNA type #6 (middle) and type #7 (bottom).
2. Results 
1.3 Molecular Dynamics
• In addition to the control, three simulations were
set up for each of the RNA types in complex
(right) with the endoribonuclease Csy4 (left).
Figure 4:
Figure 3: Rmsd plots of RNA wild type #1 (top), mutated RNA #6 (middle),
mutated RNA type #7.
Figure 1a, 1b, 1c: Comparison of the hydrogen bonds between RNA strands
and Csy4 in the control (top, type #1), type #6 (middle), and type #7
(bottom).
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• All simulations were carried out for at least 100 ns.
• All simulations used CHARMM force field.
• Periodic boundary conditions were assumed using
a constant temperature of 300K and a pressure of
1atm.
• At least 10,000 steps energy minimization was
performed first to stabilize the system, with both
fixed and unfixed atoms (but movable solvents).
• The control RNA strand, #1, was simulated for 175
ns. Strand #6 was simulated for 140 ns.
• RMSD, electrostatic interactions, etc. were used to
compare the simulations of the RNA types.
